Tirzepatide: A dual action approach to weight reduction and glycemic control in type 2 diabetes mellitus
Tirzepatide, a dual GIP and GLP-1 receptor agonist, is an innovative therapy for type 2 diabetes mellitus (T2DM) and obesity. By stimulating insulin secretion, inhibiting glucagon release, slowing gastric emptying, and enhancing satiety, it offers superior glycemic control and weight reduction compa...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | MGM Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/mgmj.mgmj_386_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!